Congress Seeks More Information on 23andMe Data Mix-up | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A US congressional committee has sent a letter to consumer genomics firm 23andMe requesting more information regarding a recent mix-up in sample processing that may have lead to some customers receiving data that was not their own.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.